Antibody to Digoxin Sheep Polyclonal

$250.00

Catalog #: A2010016 – 0.25 mL

Polyclonal antibody to Digoxin, a drug used as a beta-blocker in the treatment of several medical conditions such as congestive heart failure (CHF). Bulk pricing and biotinylation services are available.

Live Enquiry about this product via Text/SMS: 1-858-900-3210 (8 am – 8 pm PST)

In stock

SKU: A2010016 Category: Tag:

Description

Polyclonal Antibody to Digoxin

Product Data Sheet Download PDF
MSDS Download PDF
Catalog number: A2010016
Lot number: 0119A0016
Expiration date: 4/6/23
Package Size: 0.25 mL
Other names: Antibody to digoxin
Supplied as: Neat Serum Solution
Host: Sheep
Antigen: Digoxin molecule conjugated to Keyhole limpet Haemocyanin.
Clonality: Polyclonal
Preservative: 0.05% sodium azide
Storage: 2-8°C (short term), -20°C (long term). Avoid repeated freeze-thaw.
Specificity: Digoxin: 100%
Digoxigenin: 62%
Digitoxin: 5%
Oubain: 1%

 

References Related to Digoxin Antibody

  • Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort. Allen LA, Fonarow GC, Simon DN, Thomas LE, Marzec LN, Pokorney SD, Gersh BJ, Go AS, Hylek EM, Kowey PR, Mahaffey KW, Chang P, Peterson ED, Piccini JP; ORBIT-AF Investigators. J Am Coll Cardiol. 2015 Jun 30;65(25):2691-8.
  • Determination of digoxin clearance in Japanese elderly patients for optimization of drug therapy: a population pharmacokinetics analysis using nonlinear mixed-effects modelling. Yukawa M, Yukawa E, Suematsu F, Takiguchi T, Ikeda H, Aki H, Mimemoto M. Drugs Aging. 2011 Oct 1;28(10):831-41.
  • Some comments and suggestions concerning population pharmacokinetic modeling, especially of digoxin, and its relation to clinical therapy. Jelliffe RW. Ther Drug Monit. 2012 Aug;34(4):368-77.
  • Serum glycoside concentrations after single or repeated intravenous doses of beta-methyl-digoxin and digoxin. Marinow J, Olcay A, Schaumann W, Weiss W. Eur J Clin Pharmacol. 1977 Mar 11;11(3):213-8.
  • Cross reactivity of the EMIT digoxin assay with digoxin metabolites, and validation of the method for measurement of urinary digoxin. Linday L, Drayer DE. Clin Chem. 1983 Jan;29(1):175-7.
  • Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring. Englund G, Hallberg P, Artursson P, Michaëlsson K, Melhus H. BMC Med. 2004 Apr 2;2:8. doi: 10.1186/1741-7015-2-8.
  • Effect of physical exercise on the pharmacokinetics of digoxin during maintenance treatment. Jogestrand T, Andersson K. J Cardiovasc Pharmacol. 1989 Jul;14(1):73-6.